Trial: 201909070

A Target Validation/Phase1 Study of BGB-290 in Combination with Temozolomide in Adolescent and Young Adult IDH1/2 Newly Diagnosed and Recurrent Mutant Gliomas

Phase

I

Principal Investigator

Abdelbaki, Mohamed

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov